PCN77 - BUDGET IMPACT ANALYSIS OF BLINATUMOMAB FOR THE TREATMENT OF PEDIATRIC PATIENTS WITH PHILADELPHIA NEGATIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN MEXICO
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.159
https://www.valueinhealthjournal.com/article/S1098-3015(18)33459-4/fulltext
Section Title :
Section Order :
980
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33459-4&doi=10.1016/j.jval.2018.09.159